[Electrocardiographic score: application in exercise test for the assessment of ischemic preconditioning]

Arq Bras Cardiol. 2010 Oct;95(4):486-92. doi: 10.1590/s0066-782x2010005000122. Epub 2010 Sep 8.
[Article in Multiple languages]

Abstract

Background: the time for 1.0 mm ST-segment depression (T-1.0mm) adopted to characterize ischemic preconditioning (IPC) in sequential exercise tests is consistent and reproducible; however, it has several limitations.

Objective: to apply an electrocardiographic score of myocardial ischemia in sequential exercise tests, comparing it to the conventional T-1.0 mm index.

Methods: sixty one patients with mean age of 62.2 ± 7.5 years were evaluated; 86.9% were males. A total of 151 tests were analyzed, 116 of which were from patients who completed two assessment phases. The first phase comprised two sequential exercise tests for the documentation of IPC; the second phase, initiated one week later, comprised two more tests carried out under the effect of repaglinide. Two observers who were blind to the tests applied the score.

Results: Perfect inter and intraobserver agreement was found (Kendall tau-b = 0.96, p < 0.0001, and Kendall tau-b = 0.98, p < 0.0001, respectively). Values of sensitivity and specificity, negative predictive value, positive predictive value and accuracy were 72.41%, 89.29%, 75.8%, 87.5% and 81.0%, respectively.

Conclusion: the ischemic score is a consistent and reproducible method for the documentation of IPC, and is a feasible alternative to T-1.0 mm.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Carbamates
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / physiopathology*
  • Double-Blind Method
  • Electrocardiography / methods*
  • Electrocardiography / standards
  • Ergometry*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Ischemic Preconditioning*
  • Male
  • Middle Aged
  • Myocardial Ischemia / diagnosis*
  • Observer Variation
  • Piperidines
  • Predictive Value of Tests

Substances

  • Carbamates
  • Hypoglycemic Agents
  • Piperidines
  • repaglinide